Now that Vertanical’s Exilby has been approved in Germany to treat chronic pain, Clemens Fischer, the pharma billionaire behind it, has set his sights on the U.S. market.
Bringing you TOP Pot Stocks!
Now that Vertanical’s Exilby has been approved in Germany to treat chronic pain, Clemens Fischer, the pharma billionaire behind it, has set his sights on the U.S. market.
Copyright © 2026 Cannabis Stocks News